Emerging medications for suicide prediction and therapeutic strategies
- Hospice & Palliative Medicine International Journal
-
Da Yong Lu,<sup>1</sup> Hong Ying Wu,<sup>2</sup> Jin Yu Che,<sup>1</sup> Ting Ren Lu<sup>2</sup>
PDF Full Text
Abstract
Suicide has a high rate of human deaths (0.5-1.2 million deaths annually). It is suggested that large number of different factors may drive human suicide processes from thoughts to deaths. It is urgently needed for developing new therapies for human suicide. Good therapies will not success without complete understanding of its pathogenic roots. Unfortunately, the pathogenic root of human suicide has not been fully revealed. Among different risk factors, high quality clinical suicide prediction, prevention and treatment is needed. Human suicide prediction and prevention study has been translated from intangible entities into formal medication. A great deal of connection and unity between neurobiological aberration, different symptoms, and death cases is indispensable. To cope with these advances, public healthcare, biomedical foundation, and clinical databases are analyzed in this article.
Keywords
human suicide, neurobiology, psychopharmacology, drug develop, CNS disease, suicide prediction


